Jpmorgan Chase & CO Repligen Corp Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Repligen Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 192,479 shares of RGEN stock, worth $28.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

192,479

Previous 161,029 19.53%

Holding current value

$28.6 Million

Previous $23.2 Million 5.66%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$127.24 - $174.24 $4 Million - $5.48 Million	31,450 Added 19.53%	192,479 $24.5 Million
Q4 2024 Feb 12, 2025	SELL	$123.41 - $160.92 $25 Million - $32.6 Million	-202,470 Reduced 55.7%	161,029 $23.2 Million
Q3 2024 Dec 26, 2024	BUY	$119.79 - $167.35 $20.4 Million - $28.4 Million	170,000 Added 87.86%	363,499 $54.1 Million
Q3 2024 Nov 08, 2024	BUY	$119.79 - $167.35 $20.4 Million - $28.4 Million	170,000 Added 87.86%	363,499 $54.1 Million
Q2 2024 Dec 26, 2024	SELL	$120.0 - $182.95 $20.4 Million - $31.1 Million	-170,000 Reduced 46.77%	193,499 $24.4 Million
Q2 2024 Aug 12, 2024	BUY	$120.0 - $182.95 $2.92 Million - $4.45 Million	24,309 Added 14.37%	193,499 $24.4 Million
Q1 2024 Dec 26, 2024	SELL	$170.78 - $208.42 $33.2 Million - $40.5 Million	-194,309 Reduced 53.46%	169,190 $31.1 Million
Q1 2024 May 10, 2024	BUY	$170.78 - $208.42 $1.4 Million - $1.71 Million	8,186 Added 5.08%	169,190 $31.1 Million
Q4 2023 Dec 26, 2024	SELL	$114.17 - $185.35 $23.1 Million - $37.5 Million	-202,495 Reduced 55.71%	161,004 $28.9 Million
Q4 2023 Feb 12, 2024	SELL	$114.17 - $185.35 $2.4 Million - $3.89 Million	-20,989 Reduced 11.53%	161,004 $28.9 Million
Q3 2023 Nov 14, 2023	SELL	$138.78 - $176.51 $4.55 Million - $5.79 Million	-32,782 Reduced 15.26%	181,993 $28.9 Million
Q2 2023 Aug 11, 2023	BUY	$138.42 - $180.31 $860,695 - $1.12 Million	6,218 Added 2.98%	214,775 $30.4 Million
Q1 2023 May 18, 2023	BUY	$154.26 - $198.1 $13.7 Million - $17.6 Million	88,771 Added 74.11%	208,557 $35.1 Million
Q1 2023 May 11, 2023	SELL	$154.26 - $198.1 $18.6 Million - $23.9 Million	-120,790 Reduced 50.21%	119,786 $20.2 Million
Q4 2022 Feb 13, 2023	SELL	$162.42 - $220.56 $1.12 Million - $1.52 Million	-6,902 Reduced 2.79%	240,576 $40.7 Million
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $2.02 Million - $3.23 Million	-12,593 Reduced 4.84%	247,478 $46.3 Million
Q2 2022 Aug 11, 2022	BUY	$140.68 - $188.02 $636,717 - $850,978	4,526 Added 1.77%	260,071 $42.2 Million
Q1 2022 May 11, 2022	SELL	$161.19 - $257.96 $3.33 Million - $5.33 Million	-20,678 Reduced 7.49%	255,545 $48.1 Million
Q4 2021 Feb 10, 2022	SELL	$247.59 - $304.47 $8.93 Million - $11 Million	-36,087 Reduced 11.55%	276,223 $73.2 Million
Q3 2021 Nov 12, 2021	BUY	$194.77 - $324.21 $60.8 Million - $101 Million	312,310 New	312,310 $90.3 Million

Others Institutions Holding RGEN

# of Institutions

505

Shares Held

58.9M

Call Options Held

89.3K

Put Options Held

679K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.25B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Repligen Corp Transaction History